Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Am J Surg Pathol. 2013 Feb;37(2):287–294. doi: 10.1097/PAS.0b013e31826885fb

Table 1.

Clinical and pathological characteristics of lung adenocarcinomas with and without tumor islands

Variable Island (−)
n=203
Islands (+)
n=58
P value
Age (y); median (range) 69 (37–92) 68.5 (47–83) 0.253
Gender (F; %) 126 (62.1) 30 (51.7) 0.173
Smoking History (Pack-year); median (range) 30 (0–730) 40 (0–140) 0.060
Tumor size (cm); median (range) 2.3 (0.6–15.0) 2.05 (0.4–6.5) 0.283
Specimen type (wedge resection; %) 66 (32.5) 16 (27.6) 0.524
pT (%) 0.949
1a 82 (40.4) 22 (37.9)
1b 44 (21.7) 15 (25.9)
2a 57 (28.1) 16 (27.6)
2b 7 (3.4) 1 (1.7)
3 13 (6.4) 4 (6.9)
pN (%) 0.609
N0 173 (85.2) 49 (84.5)
N1 17 (8.4) 6 (10.3)
Nx 13 (6.4) 3 (5.2)
AJCC Stage 0.960
IA 116 (57.1) 35 (60.4)
IB 53 (26.1) 13 (22.4)
IIA 18 (8.9) 5 (8.6)
IIB 16 (7.9) 5 (8.6)
Predominant Histological Pattern (%) 0.003
Minimally invasive adenocarcinoma 29 (14.3) 2 (3.5)
Lepidic 34 (16.8) 4 (6.9)
Acinar 90 (44.3) 25 (43.1)
Papillary 21 (10.3) 7 (12.1)
Micropapillary 8 (3.9) 6 (10.3)
Solid 16 (7.9) 13 (22.4)
Mucinous adenocarcinoma 5 (2.5) 1 (1.7)
Nuclear Grade (%) 0.011
1 15 (7.4) 0 (0)
2 104 (51.2) 24 (41.4)
3 84 (41.4) 34 (58.6)
Lymphatic invasion (%) 45 (22.17) 19 (32.76) 0.119
Vascular invasion (%) 23 (11.3) 8 (13.8) 0.646
Pleural invasion (%) 34 (16.8) 13 (22.4) 0.336